Global and India Antacid Market Report & Forecast 2023-2029

and India Antacid Market

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

In India, the Antacid revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.

In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.

This report focuses on global and India Antacid market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Antacid will continue to grow rapidly in the future.

Global Antacid Scope and Market Size

Antacid market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Antacid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Antacid market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Antacid Market Report

1.1 Antacid Product Introduction

1.2 Global Antacid Outlook 2018 VS 2022 VS 2029

1.2.1 Global Antacid Sales in US$ Million for the Year 2018-2029

1.2.2 Global Antacid Sales in Volume for the Year 2018-2029

1.3 India Antacid Outlook 2018 VS 2022 VS 2029

1.3.1 India Antacid Sales in US$ Million for the Year 2018-2029

1.3.2 India Antacid Sales in Volume for the Year 2018-2029

1.4 Antacid Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Antacid in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Antacid Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Antacid Market Dynamics

1.5.1 Antacid Industry Trends

1.5.2 Antacid Market Drivers

1.5.3 Antacid Market Challenges

1.5.4 Antacid Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2.1 Antacid Market Segment by Type

2.1.1 Proton Pump Inhibitor

2.1.2 H2 Antagonist

2.1.3 Acid Neutralizers

2.2 Global Antacid Market Size by Type

2.2.1 Global Antacid Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Antacid Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Antacid Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Antacid Market Size by Type

2.3.1 India Antacid Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Antacid Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Antacid Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3.1 Antacid Market Segment by Application

3.1.1 OTC Drug

3.1.2 Rx Drug

3.2 Global Antacid Market Size by Application

3.2.1 Global Antacid Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Antacid Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Antacid Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Antacid Market Size by Application

3.3.1 India Antacid Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Antacid Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Antacid Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4.1 Global Antacid Market Size by Company

4.1.1 Global Key Manufacturers of Antacid, Ranked by Revenue (2022)

4.1.2 Global Antacid Revenue by Manufacturer (2018-2023)

4.1.3 Global Antacid Sales by Manufacturer (2018-2023)

4.1.4 Global Antacid Price by Manufacturer (2018-2023)

4.2 Global Antacid Concentration Ratio (CR)

4.2.1 Antacid Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antacid in 2022

4.2.3 Global Antacid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Antacid, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Antacid, Product Offered and Application

4.5 Global Key Manufacturers of Antacid, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Antacid Market Size by Company

4.7.1 Key Players of Antacid in India, Ranked by Revenue (2022)

4.7.2 India Antacid Revenue by Players (2018-2023)

4.7.3 India Antacid Sales by Players (2018-2023)

5.1 Global Antacid Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Antacid Market Size in Volume by Region (2018-2029)

5.2.1 Global Antacid Sales in Volume by Region: 2018-2023

5.2.2 Global Antacid Sales in Volume Forecast by Region (2024-2029)

5.3 Global Antacid Market Size in Value by Region (2018-2029)

5.3.1 Global Antacid Sales in Value by Region: 2018-2023

5.3.2 Global Antacid Sales in Value by Region: 2024-2029

6.1 Americas Antacid Market Size YoY Growth 2018-2029

6.2 Americas Antacid Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Antacid Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Antacid Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Antacid Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Antacid Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7.1 EMEA Antacid Market Size YoY Growth 2018-2029

7.2 EMEA Antacid Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Antacid Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Antacid Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Antacid Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Antacid Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8.1 China Antacid Market Size YoY Growth 2018-2029

8.2 China Antacid Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Antacid Sales in Volume, by Application (2018, 2022 & 2029)

9.1 APAC Antacid Market Size YoY Growth 2018-2029

9.2 APAC Antacid Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Antacid Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Antacid Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Antacid Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Antacid Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10.1 AstraZeneca

10.1.1 AstraZeneca Company Information

10.1.2 AstraZeneca Description and Business Overview

10.1.3 AstraZeneca Antacid Sales, Revenue and Gross Margin (2018-2023)

10.1.4 AstraZeneca Antacid Products Offered

10.1.5 AstraZeneca Recent Development

10.2 Takeda Pharmaceutical

10.2.1 Takeda Pharmaceutical Company Information

10.2.2 Takeda Pharmaceutical Description and Business Overview

10.2.3 Takeda Pharmaceutical Antacid Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Takeda Pharmaceutical Antacid Products Offered

10.2.5 Takeda Pharmaceutical Recent Development

10.3 Pfizer

10.3.1 Pfizer Company Information

10.3.2 Pfizer Description and Business Overview

10.3.3 Pfizer Antacid Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Pfizer Antacid Products Offered

10.3.5 Pfizer Recent Development

10.4 Reckitt Benckiser

10.4.1 Reckitt Benckiser Company Information

10.4.2 Reckitt Benckiser Description and Business Overview

10.4.3 Reckitt Benckiser Antacid Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Reckitt Benckiser Antacid Products Offered

10.4.5 Reckitt Benckiser Recent Development

10.5 Bayer

10.5.1 Bayer Company Information

10.5.2 Bayer Description and Business Overview

10.5.3 Bayer Antacid Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Bayer Antacid Products Offered

10.5.5 Bayer Recent Development

10.6 Procter＆Gamble

10.6.1 Procter＆Gamble Company Information

10.6.2 Procter＆Gamble Description and Business Overview

10.6.3 Procter＆Gamble Antacid Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Procter＆Gamble Antacid Products Offered

10.6.5 Procter＆Gamble Recent Development

10.7 GlaxoSmithKline

10.7.1 GlaxoSmithKline Company Information

10.7.2 GlaxoSmithKline Description and Business Overview

10.7.3 GlaxoSmithKline Antacid Sales, Revenue and Gross Margin (2018-2023)

10.7.4 GlaxoSmithKline Antacid Products Offered

10.7.5 GlaxoSmithKline Recent Development

10.8 Johnson＆Johnson

10.8.1 Johnson＆Johnson Company Information

10.8.2 Johnson＆Johnson Description and Business Overview

10.8.3 Johnson＆Johnson Antacid Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Johnson＆Johnson Antacid Products Offered

10.8.5 Johnson＆Johnson Recent Development

10.9 CONBA

10.9.1 CONBA Company Information

10.9.2 CONBA Description and Business Overview

10.9.3 CONBA Antacid Sales, Revenue and Gross Margin (2018-2023)

10.9.4 CONBA Antacid Products Offered

10.9.5 CONBA Recent Development

10.10 Xiuzheng Pharma

10.10.1 Xiuzheng Pharma Company Information

10.10.2 Xiuzheng Pharma Description and Business Overview

10.10.3 Xiuzheng Pharma Antacid Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Xiuzheng Pharma Antacid Products Offered

10.10.5 Xiuzheng Pharma Recent Development

10.11 Sanofi

10.11.1 Sanofi Company Information

10.11.2 Sanofi Description and Business Overview

10.11.3 Sanofi Antacid Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Sanofi Antacid Products Offered

10.11.5 Sanofi Recent Development

10.12 Bausch Health

10.12.1 Bausch Health Company Information

10.12.2 Bausch Health Description and Business Overview

10.12.3 Bausch Health Antacid Sales, Revenue and Gross Margin (2018-2023)

10.12.4 Bausch Health Antacid Products Offered

10.12.5 Bausch Health Recent Development

10.13 CR SANJIU

10.13.1 CR SANJIU Company Information

10.13.2 CR SANJIU Description and Business Overview

10.13.3 CR SANJIU Antacid Sales, Revenue and Gross Margin (2018-2023)

10.13.4 CR SANJIU Antacid Products Offered

10.13.5 CR SANJIU Recent Development

10.14 Reddy's Laboratories

10.14.1 Reddy's Laboratories Company Information

10.14.2 Reddy's Laboratories Description and Business Overview

10.14.3 Reddy's Laboratories Antacid Sales, Revenue and Gross Margin (2018-2023)

10.14.4 Reddy's Laboratories Antacid Products Offered

10.14.5 Reddy's Laboratories Recent Development

11.1 Antacid Industry Chain Analysis

11.2 Antacid Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Antacid Production Mode & Process

11.4 Antacid Sales and Marketing

11.4.1 Antacid Sales Channels

11.4.2 Antacid Distributors

11.5 Antacid Customers

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Antacid CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

    Table 2. Antacid Market Trends

    Table 3. Antacid Market Drivers

    Table 4. Antacid Market Challenges

    Table 5. Antacid Market Restraints

    Table 6. Global Antacid Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

    Table 7. India Antacid Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

    Table 8. Global Antacid Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

    Table 9. India Antacid Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

    Table 10. Global Key Manufacturers of Antacid, Ranked by Revenue (2022) & (US$ Million)

    Table 11. Global Antacid Revenue by Manufacturer, (US$ Million), 2018-2023

    Table 12. Global Antacid Revenue Share by Manufacturer, 2018-2023

    Table 13. Global Antacid Sales by Manufacturer, (M Units), 2018-2023

    Table 14. Global Antacid Sales Share by Manufacturer, 2018-2023

    Table 15. Global Antacid Price by Manufacturer (2018-2023) & (USD/Unit)

    Table 16. Global Antacid Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 17. Global Antacid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antacid as of 2022)

    Table 18. Global Key Manufacturers of Antacid, Manufacturing Base Distribution and Headquarters

    Table 19. Global Key Manufacturers of Antacid, Product Offered and Application

    Table 20. Global Key Manufacturers of Antacid, Date of Enter into This Industry

    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 22. Key Players of Antacid in India, Ranked by Revenue (2022) & (US$ million)

    Table 23. India Antacid Revenue by Players, (US$ Million), (2018-2023)

    Table 24. India Antacid Revenue Share by Players, (2018-2023)

    Table 25. India Antacid Sales by Players, (M Units), (2018-2023)

    Table 26. India Antacid Sales Share by Players, (2018-2023)

    Table 27. Global Antacid Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 28. Global Antacid Sales in Volume by Region (2018-2023) & (M Units)

    Table 29. Global Antacid Sales in Volume Forecast by Region (2024-2029) & (M Units)

    Table 30. Global Antacid Sales in Value by Region (2018-2023) & (US$ Million)

    Table 31. Global Antacid Sales in Value Forecast by Region (2024-2029) & (US$ Million)

    Table 32. Americas Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. Americas Antacid Sales in Value by Country (2018-2023) & (US$ Million)

    Table 34. Americas Antacid Sales in Value by Country (2024-2029) & (US$ Million)

    Table 35. Americas Antacid Sales in Volume by Country (2018-2023) & (M Units)

    Table 36. Americas Antacid Sales in Volume by Country (2024-2029) & (M Units)

    Table 37. EMEA Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. EMEA Antacid Sales in Value by Country (2018-2023) & (US$ Million)

    Table 39. EMEA Antacid Sales in Value by Country (2024-2029) & (US$ Million)

    Table 40. EMEA Antacid Sales in Volume by Country (2018-2023) & (M Units)

    Table 41. EMEA Antacid Sales in Volume by Country (2024-2029) & (M Units)

    Table 42. APAC Antacid Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. APAC Antacid Sales in Value by Country (2018-2023) & (US$ Million)

    Table 44. APAC Antacid Sales in Value by Country (2024-2029) & (US$ Million)

    Table 45. APAC Antacid Sales in Volume by Country (2018-2023) & (M Units)

    Table 46. APAC Antacid Sales in Volume by Country (2024-2029) & (M Units)

    Table 47. AstraZeneca Company Information

    Table 48. AstraZeneca Description and Business Overview

    Table 49. AstraZeneca Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 50. AstraZeneca Antacid Product

    Table 51. AstraZeneca Recent Development

    Table 52. Takeda Pharmaceutical Company Information

    Table 53. Takeda Pharmaceutical Description and Business Overview

    Table 54. Takeda Pharmaceutical Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 55. Takeda Pharmaceutical Antacid Product

    Table 56. Takeda Pharmaceutical Recent Development

    Table 57. Pfizer Company Information

    Table 58. Pfizer Description and Business Overview

    Table 59. Pfizer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 60. Pfizer Antacid Product

    Table 61. Pfizer Recent Development

    Table 62. Reckitt Benckiser Company Information

    Table 63. Reckitt Benckiser Description and Business Overview

    Table 64. Reckitt Benckiser Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 65. Reckitt Benckiser Antacid Product

    Table 66. Reckitt Benckiser Recent Development

    Table 67. Bayer Company Information

    Table 68. Bayer Description and Business Overview

    Table 69. Bayer Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 70. Bayer Antacid Product

    Table 71. Bayer Recent Development

    Table 72. Procter＆Gamble Company Information

    Table 73. Procter＆Gamble Description and Business Overview

    Table 74. Procter＆Gamble Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 75. Procter＆Gamble Antacid Product

    Table 76. Procter＆Gamble Recent Development

    Table 77. GlaxoSmithKline Company Information

    Table 78. GlaxoSmithKline Description and Business Overview

    Table 79. GlaxoSmithKline Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 80. GlaxoSmithKline Antacid Product

    Table 81. GlaxoSmithKline Recent Development

    Table 82. Johnson＆Johnson Company Information

    Table 83. Johnson＆Johnson Description and Business Overview

    Table 84. Johnson＆Johnson Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 85. Johnson＆Johnson Antacid Product

    Table 86. Johnson＆Johnson Recent Development

    Table 87. CONBA Company Information

    Table 88. CONBA Description and Business Overview

    Table 89. CONBA Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 90. CONBA Antacid Product

    Table 91. CONBA Recent Development

    Table 92. Xiuzheng Pharma Company Information

    Table 93. Xiuzheng Pharma Description and Business Overview

    Table 94. Xiuzheng Pharma Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 95. Xiuzheng Pharma Antacid Product

    Table 96. Xiuzheng Pharma Recent Development

    Table 97. Sanofi Company Information

    Table 98. Sanofi Description and Business Overview

    Table 99. Sanofi Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 100. Sanofi Antacid Product

    Table 101. Sanofi Recent Development

    Table 102. Bausch Health Company Information

    Table 103. Bausch Health Description and Business Overview

    Table 104. Bausch Health Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 105. Bausch Health Antacid Product

    Table 106. Bausch Health Recent Development

    Table 107. CR SANJIU Company Information

    Table 108. CR SANJIU Description and Business Overview

    Table 109. CR SANJIU Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 110. CR SANJIU Antacid Product

    Table 111. CR SANJIU Recent Development

    Table 112. Reddy's Laboratories Company Information

    Table 113. Reddy's Laboratories Description and Business Overview

    Table 114. Reddy's Laboratories Antacid Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 115. Reddy's Laboratories Antacid Product

    Table 116. Reddy's Laboratories Recent Development

    Table 117. Key Raw Materials Lists

    Table 118. Raw Materials Key Suppliers Lists

    Table 119. Antacid Customers List

    Table 120. Antacid Distributors List

    Table 121. Research Programs/Design for This Report

    Table 122. Key Data Information from Secondary Sources

    Table 123. Key Data Information from Primary Sources

List of Figures

    Figure 1. Antacid Product Picture

    Figure 2. Global Antacid Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 3. Global Antacid Market Size 2018-2029 (US$ Million)

    Figure 4. Global Antacid Sales 2018-2029 (M Units)

    Figure 5. India Antacid Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 6. India Antacid Market Size 2018-2029 (US$ Million)

    Figure 7. India Antacid Sales 2018-2029 (M Units)

    Figure 8. India Antacid Market Share in Global, in Value (US$ Million) 2018-2029

    Figure 9. India Antacid Market Share in Global, in Volume (M Units) 2018-2029

    Figure 10. Antacid Report Years Considered

    Figure 11. Product Picture of Proton Pump Inhibitor

    Figure 12. Product Picture of H2 Antagonist

    Figure 13. Product Picture of Acid Neutralizers

    Figure 14. Global Antacid Market Share by Type in 2022 & 2029

    Figure 15. Global Antacid Sales in Value by Type (2018-2029) & (US$ Million)

    Figure 16. Global Antacid Sales Market Share in Value by Type (2018-2029)

    Figure 17. Global Antacid Sales by Type (2018-2029) & (M Units)

    Figure 18. Global Antacid Sales Market Share in Volume by Type (2018-2029)

    Figure 19. Global Antacid Price by Type (2018-2029) & (USD/Unit)

    Figure 20. India Antacid Market Share by Type in 2022 & 2029

    Figure 21. India Antacid Sales in Value by Type (2018-2029) & (US$ Million)

    Figure 22. India Antacid Sales Market Share in Value by Type (2018-2029)

    Figure 23. India Antacid Sales by Type (2018-2029) & (M Units)

    Figure 24. India Antacid Sales Market Share in Volume by Type (2018-2029)

    Figure 25. India Antacid Price by Type (2018-2029) & (USD/Unit)

    Figure 26. Product Picture of OTC Drug

    Figure 27. Product Picture of Rx Drug

    Figure 28. Global Antacid Market Share by Application in 2022 & 2029

    Figure 29. Global Antacid Sales in Value by Application (2018-2029) & (US$ Million)

    Figure 30. Global Antacid Sales Market Share in Value by Application (2018-2029)

    Figure 31. Global Antacid Sales by Application (2018-2029) & (M Units)

    Figure 32. Global Antacid Sales Market Share in Volume by Application (2018-2029)

    Figure 33. Global Antacid Price by Application (2018-2029) & (USD/Unit)

    Figure 34. India Antacid Market Share by Application in 2022 & 2029

    Figure 35. India Antacid Sales in Value by Application (2018-2029) & (US$ Million)

    Figure 36. India Antacid Sales Market Share in Value by Application (2018-2029)

    Figure 37. India Antacid Sales by Application (2018-2029) & (M Units)

    Figure 38. India Antacid Sales Market Share in Volume by Application (2018-2029)

    Figure 39. India Antacid Price by Application (2018-2029) & (USD/Unit)

    Figure 40. Americas Antacid Sales in Volume Growth Rate 2018-2029 (M Units)

    Figure 41. Americas Antacid Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 42. Americas Antacid Sales by Type (2018-2029) & (M Units)

    Figure 43. Americas Antacid Sales Market Share in Volume by Type (2018-2029)

    Figure 44. Americas Antacid Sales by Application (2018-2029) & (M Units)

    Figure 45. Americas Antacid Sales Market Share in Volume by Application (2018-2029)

    Figure 46. United States Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Canada Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Mexico Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Brazil Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 50. EMEA Antacid Sales in Volume Growth Rate 2018-2029 (M Units)

    Figure 51. EMEA Antacid Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 52. EMEA Antacid Sales by Type (2018-2029) & (M Units)

    Figure 53. EMEA Antacid Sales Market Share in Volume by Type (2018-2029)

    Figure 54. EMEA Antacid Sales by Application (2018-2029) & (M Units)

    Figure 55. EMEA Antacid Sales Market Share in Volume by Application (2018-2029)

    Figure 56. Europe Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Middle East Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Africa Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 59. China Antacid Sales in Volume Growth Rate 2018-2029 (M Units)

    Figure 60. China Antacid Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 61. China Antacid Sales by Type (2018-2029) & (M Units)

    Figure 62. China Antacid Sales Market Share in Volume by Type (2018-2029)

    Figure 63. China Antacid Sales by Application (2018-2029) & (M Units)

    Figure 64. China Antacid Sales Market Share in Volume by Application (2018-2029)

    Figure 65. APAC Antacid Sales in Volume Growth Rate 2018-2029 (M Units)

    Figure 66. APAC Antacid Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 67. APAC Antacid Sales by Type (2018-2029) & (M Units)

    Figure 68. APAC Antacid Sales Market Share in Volume by Type (2018-2029)

    Figure 69. APAC Antacid Sales by Application (2018-2029) & (M Units)

    Figure 70. APAC Antacid Sales Market Share in Volume by Application (2018-2029)

    Figure 71. Japan Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 72. South Korea Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 73. China Taiwan Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 74. Southeast Asia Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 75. India Antacid Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 76. Antacid Value Chain

    Figure 77. Antacid Production Process

    Figure 78. Channels of Distribution

    Figure 79. Distributors Profiles

    Figure 80. Bottom-up and Top-down Approaches for This Report

    Figure 81. Data Triangulation

    Figure 82. Key Executives Interviewed